HWN Suggests

Neonatal Supraventricular Tachycardia - A Review of Literature

Supraventricular tachycardia (SVT) is the most challenging arrhythmia in newborn, requiring urgent medical attention...

Adenosine, when administered in the correct dose with the correct means is very effective with success rates of 85% to 100% [38]. Adenosine appears to be the most promising antiarrhythmic agent. Adenosine can be given in a starting dose of 0.1 mg/kg, increasing by 0.1mg/kg increment at 2 minutes interval till sinus rhythm is restored.

read full article

Featured

 Neonatal arrhythmias: diagnosis, treatment, and clinical outcome

Supraventricular tachycardia, ventricular tachycardia, atrioventricular conduction abnormalities, and genetic arrhythmia such as congenital long-QT syndrome are classified as nonbenign arrhythmias.

Articles of Interest

Best Case Ever 47 – Cyanotic Infant

The Cyanotic Infant can present a significant challenge to the EM provider as the differential is wide, ranging from benign causes such as GERD to life threatening heart disease that may present atypically in a well-appearing child.

Cardiac Emergencies in the First Year of Life

In approaching cardiac emergencies, cardiac disease can be divided into structural disease, conduction abnormalities, and acquired illnesses. While recognizing that many lesions can be a combination of many defects, structural congenital heart disease can be divided into cyanotic and acyanotic categories.

Episode 84 – Congenital Heart Disease Emergencies

You might be surprised to learn that the prevalence of critical cardiac disease in infants is almost as high as the prevalence of infant sepsis. And if you’re like me, you don’t feel quite as confident managing sick infants with critical heart disease as you do managing sepsis.

Management of Neonatal Supraventricular Tachycardias; A Single Center Experience

Supraventricular tachycardia may lead to cardiac failure and cardiovascular collapse; and it is an important cause of morbidity and mortality in newborns. Adenosine is the first-line treatment with high efficacy and safety.

Neonatal Cardiac Emergencies: Management Strategies

Several types of arrhythmias are seen in the neonate; most of them are benign. However, supraventricular tachycardia (SVT), the most common rhythm disorder in this age group, may cause significant hemodynamic disturbance

Neonatal supraventricular tachycardia

Most episodes of neonatal supraventricular tachycardia (SVT) only last for a few minutes and do not need urgent treatment. Some babies are affected by episodes that last longer so you may be given regular medication to reduce or stop the chance of prolonged periods of SVT. This is often a beta blocker medicine to keep the child’s heart rate regular. Other medicines such as flecanide, digoxin and amiodarone can also be used.

Pediatric Cardiac Emergencies

Children Have Hearts... Things can go wrong with them.

Pediatric cardiac emergencies

With major advances in the field of pediatric cardiology over the past few decades, outlook for children with congenital heart disease has improved immensely. Congenital heart defects, which were once considered incompatible with life, are now regularly managed immediately after birth with good survival. Better understanding of basic cardiovascular physiology behind such emergencies, has led to more focused and etiology oriented management resulting in better outcome.

Pediatric Dysrhythmias

Most common are; Sinus Tach -50%, SVT - 13%...

Pediatric Small Talk – The 1,3,5 Approach to Pediatric Cardiac Arrest

the outcomes are typically poor. Less than 10% of pediatric patients survive cardiac arrest, and only about a third of those who do survive will have a good neurologic outcome.

Treatment of supraventricular tachycardia in infants: analysis of a large multicenter database

Amiodarone was the most commonly used acute therapy in our cohort. Amiodarone therapy for acute management of recurrent adenosine-refractory SVT in children has been reported previously, including one retrospective study comparing its safety and efficacy to procainamide